◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC

CIK: 1730430 SIC: 2834
$597.97M
Revenue
$35.92M
Net Income
87.52%
Gross Margin
6.38%
Op. Margin
$174.11M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 7 of 7 annual reports available (2018 - 2024)
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
+ Total Revenue $597.97M $423.24M $270.26M $220.18M $38.54M - - -
Revenue Growth % 41.3% 56.6% 22.7% 471.2% nan% nan% nan% nan%
Cost of Revenue $74.62M $60.91M $33.41M $22.89M $9.10M - - -
+ Gross Profit $523.35M $362.33M $236.85M $197.28M $29.44M - - -
Gross Margin % 87.5% 85.6% 87.6% 89.6% 76.4% nan% nan% nan%
Operating Expenses - - - - - $157.36M $169.96M $108.16M
Research & Development $97.46M $111.62M $76.10M $65.49M $99.30M $112.04M $135.00M $86.60M
Selling General & Admin $180.03M $168.01M $129.43M $97.95M $85.95M $45.32M $34.96M -
+ Operating Income $38.15M $-45.62M $-25.20M $9.77M $-156.64M $-157.36M $-169.96M $-108.16M
Operating Margin % 6.4% -10.8% -9.3% 4.4% -406.4% nan% nan% nan%
Interest Income - $9.04M $8.23M - $97.00K $1.13M $6.05M $4.72M
Income Before Tax $48.62M $-36.15M $-16.65M $11.03M $-156.54M $-156.23M $-163.91M $-103.44M
Income Tax Expense $12.70M $7.04M $-30.74M $-172.34M $1.39M $5.15M $-2.05M $-214.00K
+ Net Income $35.92M $-43.19M $14.08M $183.36M $-157.92M $-161.38M $-161.87M $-103.23M
Net Margin % 6.0% -10.2% 5.2% 83.3% -409.7% nan% nan% nan%
Basic EPS 0.49 -0.60 0.20 2.64 -2.30 -2.61 -2.99 nan
Diluted EPS 0.45 -0.60 0.20 2.60 -2.30 -2.61 -2.99 nan
Basic Shares Outstanding 74.7M 71.4M 70.1M 69.4M 68.6M 61.8M 54.0M -
Diluted Shares Outstanding 80.0M 71.4M 71.9M 70.4M 68.6M 61.8M 54.0M -
Breakdown FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
Cash & Cash Equivalents $183.58M $107.95M $122.72M $122.47M $114.04M $46.93M $71.98M
Short-term Investments $60.05M $98.42M $67.89M $59.73M $209.44M $186.45M $235.33M
Accounts Receivable $41.72M $21.27M $12.66M $3.98M - - -
Inventory $26.36M $31.12M $21.60M $3.67M - - -
Other Current Assets $20.08M $17.54M $10.54M $6.58M $9.56M $8.25M $6.45M
Total Current Assets $331.80M $276.30M $243.06M $196.45M $333.25M $241.63M $313.75M
Property Plant & Equipment $662.00K $734.00K $1.66M $2.83M $4.05M $6.40M $6.36M
Intangible Assets $16.25M $17.25M $18.25M $19.25M - - -
Other Non-current Assets $10.31M $827.00K $5.82M $8.72M $5.59M - -
Total Assets $580.55M $526.32M $459.67M $232.80M $349.46M $254.53M $321.96M
Accounts Payable $2.04M $8.25M $7.90M $1.87M $503.00K $5.69M $10.92M
Accrued Liabilities $32.35M $44.67M $30.11M $38.03M $29.20M $20.41M $16.42M
Deferred Revenue - $307.00K - - - - -
Other Current Liabilities $16.08M $8.19M $5.75M $1.54M $37.00K $25.00K $218.00K
Total Current Liabilities $100.62M $63.67M $47.07M $44.82M $31.85M $27.83M $42.55M
Other Non-current Liabilities $1.82M $1.86M $1.84M $270.00K $805.00K $326.00K $144.00K
Total Liabilities $142.12M $87.48M $63.52M $47.76M $37.53M $29.11M $42.70M
Retained Earnings $-521.14M $-477.95M $-492.03M $-675.40M $-517.47M $-356.09M $-194.22M
Total Stockholders Equity $438.44M $438.84M $396.15M $185.04M $311.94M $225.42M $279.27M
Total Liabilities & Equity $580.55M $526.32M $459.67M $232.80M $349.46M $254.53M $321.96M
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
Net Income $44.46M $-43.19M $14.08M $183.36M $-157.92M $-161.38M $-161.87M $-103.23M
Depreciation & Amortization $2.54M $1.70M $2.34M $2.40M $2.35M $2.40M $2.07M -
Stock-based Compensation $42.81M $30.69M $27.15M $25.12M $25.17M $20.88M $15.08M $5.70M
Deferred Income Tax $9.69M $8.13M $-33.79M $-185.50M $11.00K $4.36M $-3.16M $-978.00K
Change in Receivables $15.38M $20.46M $8.61M $8.68M $3.91M - - -
Change in Inventory $30.24M $-4.76M $9.52M $17.92M $3.67M - - -
Change in Payables $5.03M $-6.31M $347.00K $6.03M $1.37M $-4.97M $-4.71M $8.82M
Operating Cash Flow $175.60M $25.69M $13.30M $5.81M $-126.30M $-136.53M $-158.37M $-81.01M
Capital Expenditure $1.49M $277.00K $130.00K $105.00K $415.00K $283.00K $3.20M $5.29M
Investing Cash Flow $-159.85M $37.67M $-29.56M $-8.08M $128.63M $-23.44M $49.21M $-239.20M
Financing Cash Flow $43.74M $12.27M $1.50M $2.52M $5.88M $227.09M $84.11M $346.74M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $180.85M - $475.44M -
Cost of Revenue $20.26M - $56.73M -
Research & Development $24.17M - $62.24M -
Selling General & Admin $49.10M - $139.50M -
Operating Income $24.02M - $57.45M -
Income Before Tax $27.16M - $65.60M -
Income Tax Expense $8.72M - $20.79M -
Net Income $18.43M $-3.91M $44.81M -
Basic EPS 0.25 - 0.61 -
Diluted EPS 0.23 - 0.57 -
Basic Shares Outstanding $74.71M - $73.61M -
Diluted Shares Outstanding $80.04M - $78.03M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $174.86M $183.58M
Short-term Investments $177.24M $60.05M
Accounts Receivable $51.74M $41.72M
Inventory $41.40M $26.36M
Other Current Assets $30.29M $20.08M
Total Current Assets $475.53M $331.80M
Property Plant & Equipment $1.66M $662.00K
Intangible Assets $15.50M $16.25M
Other Non-current Assets $8.29M $10.31M
Total Assets $712.33M $580.55M
Accounts Payable $6.15M $2.04M
Accrued Liabilities $30.94M $32.35M
Other Current Liabilities $20.52M $16.08M
Total Current Liabilities $123.59M $100.62M
Other Non-current Liabilities $14.53M $1.82M
Total Liabilities $176.95M $142.12M
Retained Earnings $-476.34M $-521.14M
Total Stockholders Equity $535.38M $438.44M
Total Liabilities & Equity $712.33M $580.55M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $18.43M $-3.91M $44.81M -
Depreciation & Amortization - - $1.09M -
Stock-based Compensation $10.14M - $26.77M -
Deferred Income Tax $4.23M - $9.86M -
Change in Receivables - - $10.02M -
Change in Inventory - - $15.03M -
Change in Payables - - $4.26M -
Operating Cash Flow - - $84.09M -
Capital Expenditure - - $935.00K -
Investing Cash Flow - - $-118.18M -
Financing Cash Flow - - $25.36M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...